Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimers Disease in the Asia-Pacific Region

摘要

BackgroundThe ‘Asia-Pacific Expert Panel (APEX) for donepezil 23 mg’ met in November 2015 to review evidence for the recently approved high dose of donepezil and to provide recommendations to help physicians in Asia make informed clinical decisions about using donepezil 23 mg in patients with moderate-to-severe Alzheimer's disease (AD).